Page 87 - Amgen News Today

Lodestone Wealth Management LLC reduced its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,218 shares of the medical research company’s stock after selling 729 shares […]

Crown Wealth Group LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 784 shares of the medical research company’s stock, valued at approximately $226,000. A number of other large investors also recently modified their holdings of the business. Southland Equity Partners LLC boosted […]

By Patrick Wingrove (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor U.S. sales of its biosimilar version of AbbVie’s blockbuster arthritis treatment Humira. The German drugmaker said it planned ...

KG&L Capital Management LLC cut its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,123 shares of the medical research company’s stock after selling 130 shares during the period. KG&L Capital Management LLC’s holdings in Amgen were worth $611,000 at the end of the […]

Farmers & Merchants Trust Co of Chambersburg PA increased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 37.6% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 534 shares of the medical research company’s stock after buying an additional 146 shares during the quarter. Farmers & […]

Use the recent short-term weakness from these powerhouse companies' stocks to your advantage.

Lewis Asset Management LLC bought a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,011 shares of the medical research company’s stock, valued at approximately $291,000. Several other hedge funds have also […]

NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US CLOSED 6 BILLION DOLLAR SERIES B DEAL GlobeNewswire April 05, 2024 SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- Silicon Valley-based Neurotechnology Powerhouse, announced that it launched its non-invasive iBrain™ Personal Brain Monitor, in 4 US states on Friday and sold 1.4% of...

KG&L Capital Management LLC reduced its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,123 shares of the medical research company’s stock after selling 130 shares during […]

Traveka Wealth LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 697 shares of the medical research company’s stock, valued at approximately $201,000. Several other hedge funds and other institutional […]